These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3936157)

  • 1. Effects of chemotherapy on mice submitted to multiple Schistosoma mansoni infections. A controlled randomized prospective study.
    da Silva LC; Alves VA; Abrantes CP; Lima DM; Christo CH; De Brito T
    Trop Med Parasitol; 1985 Sep; 36(3):150-4. PubMed ID: 3936157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver morphology with emphasis on bile ducts changes and survival analysis in mice submitted to multiple Schistosoma mansoni infections and chemotherapy.
    da Silva LC; Vianna MR; Abrantes CP; Lima DM; Falavigna AL; Antonelli-Cardoso RH; Gallucci SD; de Brito T
    Rev Inst Med Trop Sao Paulo; 1990; 32(5):328-37. PubMed ID: 2135473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of Schistosoma mansoni prevalent in Saudi Arabia to oxamniquine in experimentally infected mice.
    Amin AM; Mikhail EG
    J Trop Med Hyg; 1988 Aug; 91(4):192-5. PubMed ID: 3136251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Schistosoma mansoni infection with oxamniquine in Riyadh, Saudi Arabia.
    Al-Aska AK
    Trop Med Parasitol; 1985 Dec; 36(4):213-4. PubMed ID: 3937212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of Schistosomiasis mansoni with a combination oxamniquine and praziquantel. II. Experimental observations during the patent phase].
    Campos R; Pinto PL; Amato Neto V; Moreira AA
    Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(3):111-4. PubMed ID: 2515575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ELISA detection of specific circulating antibodies against Schistosoma mansoni in mice after treatment with oxamniquine.
    Coelho PM; Tavares CA
    Braz J Med Biol Res; 1991; 24(5):485-93. PubMed ID: 1823263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerance of Kenyan Schistosoma mansoni to oxamniquine.
    Coles GC; Mutahi WT; Kinoti GK; Bruce JI; Katz N
    Trans R Soc Trop Med Hyg; 1987; 81(5):782-5. PubMed ID: 3130689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schistosoma mansoni: tegumental surface alterations following oxamniquine treatment of infected mice.
    Amin AM; Mikhail EG
    J Egypt Soc Parasitol; 1989 Dec; 19(2 Suppl):815-26. PubMed ID: 2507653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schistosoma mansoni: the therapeutic efficacy of oxamniquine is enhanced by immune serum.
    Lambertucci JR; Modha J; Doenhoff M
    Trans R Soc Trop Med Hyg; 1989; 83(3):362-3. PubMed ID: 2515623
    [No Abstract]   [Full Text] [Related]  

  • 10. Randomized comparative trials of single doses of the newer antischistosomal drugs at Mwanza, Tanzania. I. Praziquantel and oxamniquine for the treatment of schistosomiasis mansoni.
    Rugemalila JB; Asila J; Chimbe A
    J Trop Med Hyg; 1984 Dec; 87(6):231-5. PubMed ID: 6398833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of praziquantel and oxamniquine on a Saudi Arabian strain of Schistosoma mansoni in mice.
    Ghandour AM; Banaja AA; Shalaby IM
    J Helminthol; 1990 Mar; 64(1):62-4. PubMed ID: 2110944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of schistosomiasis mansoni with a combination of oxamniquine and praziquantel. I--Experimental observations related to the pre-patent phase].
    Campos R; Pinto PL; de Sant'Ana EJ; Moreira AA; Amato Neto V
    Rev Hosp Clin Fac Med Sao Paulo; 1987; 42(5):201-3. PubMed ID: 3135570
    [No Abstract]   [Full Text] [Related]  

  • 13. [Efficacy of UK 4271 (oxamniquine, Pfizer) in Schistosoma mansoni bilharziasis in western Africa (parasitological and serological study of 252 children)].
    Nozais JP; Geunier M
    Bull Soc Pathol Exot Filiales; 1979; 72(2):153-64. PubMed ID: 527159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schistosoma mansoni cationic egg antigens (CEF6): immunoserology with oxamniquine-treated patients and involvement of CEF6 in the circumoval precipitin reaction.
    Dunne DW; Hillyer GV; Vazquez G
    Am J Trop Med Hyg; 1988 May; 38(3):508-14. PubMed ID: 3152779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schistosoma mansoni: acquired immunity in mice after the use of oxamniquine at the evolutive skin and pulmonary phases.
    Coelho PM; Mello RT; Gerken SE
    Rev Inst Med Trop Sao Paulo; 1991; 33(1):28-31. PubMed ID: 1843393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of oral therapy of mansonial schistosomiasis in the Sudan using single and multiple doses of hycanthone and oxamniquine drugs.
    Magzoub M; Adam SE
    J Pharmacol Exp Ther; 1978 Aug; 206(2):382-7. PubMed ID: 682120
    [No Abstract]   [Full Text] [Related]  

  • 17. Preliminary clinical trial of oral oxamniquine in the treatment of Schistosoma mansoni in children in Ethiopia.
    Ayele T
    East Afr Med J; 1986 Apr; 63(4):291-4. PubMed ID: 3089756
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of patients with schistosomiasis mansoni: a double blind clinical trial comparing praziquantel with oxamniquine.
    da Silva LC; Zeitune JM; Rosa-Eid LM; Lima DM; Antonelli RH; Christo CH; Saez-Alquezar A; Carboni Ade C
    Rev Inst Med Trop Sao Paulo; 1986; 28(3):174-80. PubMed ID: 3103198
    [No Abstract]   [Full Text] [Related]  

  • 19. Oxamniquine (Vansil) in the treatment of Schistosoma mansoni infections in Rhodesia.
    de V Clarke V
    Cent Afr J Med; 1977 Nov; 23(11 Suppl):20-3. PubMed ID: 606374
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of worm burdens in experimental schistosomiasis.
    Fulford AJ; Yeang F
    Parasitology; 1988 Oct; 97 ( Pt 2)():303-15. PubMed ID: 3143991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.